Latent Membrane Protein-1 Oncogene Deletions in Nasopharyngeal Carcinoma in Caucasian Patients

References

• Vasef MA, Fedito A, Weiss LM. Nasopharyngeal carcinoma, with emphasis on its relationship to Ep-stein-Barr virus. Ann Otol Rhinol Laryngol 1997; 106: 348–56.
   PubMed Web of Science ®Google Scholar
• Vera-Sempere FJ, Burgos JS, Botella MS, Cordoba J. Comparative analysis of Epstein-Barr virus (EBV) detection by nested-PCR and non-isotopic in situ hybridization in nasopharyngeal carcinoma. Clin Chim Acta 1998; 271: 119–32.
   Google Scholar
• Plaza G, Sant�n A, Manzanal AI, Mart�nez-Montero JC, Bellas C. Association of Epstein-Barr virus to nasopharyngeal carcinoma in Caucasian patients. Ann Otol Rhinol Laryngol 2002; 111: 210 6.
   Google Scholar
• Carbone A, Dolcetti R, Shaha AR, et al. What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type? Acta Otolaryngol 2001; 121: 884–95.
   PubMed Web of Science ®Google Scholar
• Hu L-F, Zabarovsky ER, Chen F, et al. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carci�noma. Eur J Cancer 1995; 31A: 658–60.
   Google Scholar
• Hu LF, Zabarovsky ER, Chen F, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991; 72: 2399–409.
   PubMed Web of Science ®Google Scholar
• Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlation with malignancy in Epstein-Barr virus-associated lymphoproliferative dis-orders and malignant lymphomas. Blood 1996; 88: 242–51.
   PubMed Web of Science ®Google Scholar
• Cheung ST, Lo KW, Leung SF, et al. Prevalence of LMP1 deletion variant of Epstein-Barr virus in naso-pharyngeal carcinoma and gastric tumors in Hong-Kong [Letter]. Int J Cancer 1996; 66: 711–2.
   PubMed Web of Science ®Google Scholar
• Chang Y-S, Su I-J, Shu C-H, Ng C-K, Wu S-J, Liu S-T. Detection of an Epstein-Barr virus variant in T-cell lymphoma tissues identical to the distinct strain ob�served in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995; 62: 673–7.
   Google Scholar
• Chen W-G, Chen Y-Y, Bacchi M-M, Bacchi CE, Alvarenga M, Weiss LE. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 1996; 148: 17–23.
   Google Scholar
• Itakura O, Yamada S, Narita M, Kikuta H. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population. Oncogene 1996; 13: 1549–53.
   PubMed Web of Science ®Google Scholar
• Dolcetti R, Zancai P, De Re V, et al. Epstein-Barr virus strains with latent membrane protein-1 deletions: pre-valence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 1997; 89: 1723–31.
   PubMed Web of Science ®Google Scholar
• Knecht H, Raphael M, McQuain C, et al. Deletion variants within the NF-KB activation domain of the LMP-1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproli-ferations. Blood 1996; 87: 876–81.
   PubMed Web of Science ®Google Scholar
• Bellas C, Sant�n A, Manzanal A, et al. Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection: comparison with ordinary Hodgkin's disease. Am J Surg Pathol 1996; 20: 1520–4.
   PubMed Web of Science ®Google Scholar
• Sant�n A, Martin C, Manzanal AI, Preciado MV, Bellas C. Pediatrie Hodgkin's disease in Spain: association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections. B J Haematol 1998; 103: 129–36.
   PubMed Web of Science ®Google Scholar
• Plaza G. Coinfection by multiple strains of Epstein-Barr virus in infectious mononucleosis in immunocompetent patients. Acta Otolaryngol 2003; 123: 000–000.
   Web of Science ®Google Scholar
• Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkerati-nizing, and squamous cell carcinoma of the nasophar�ynx: variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146: 1355–67.
   Google Scholar
• Horikawa T, Sheen TS, Takeshita H, Sato H, Furukawa M, Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol 2001; 159: 27–33.
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Horikawa T, Qing-Chun R, et al. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in naso�pharyngeal carcinoma. Clin Cancer Res 2001; 7: 1946� 51.
   Google Scholar
• Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 2000; 89: 715–23.
   Google Scholar
• Lin S Y, Tsang NM, Kao SC, et al. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyn�geal carcinoma. Head Neck 2001; 23: 194–200.
   PubMed Web of Science ®Google Scholar
• Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Clonal proliferation of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333: 693–8.
   Google Scholar
• Santon A, Bellas C. Deletions within the Epstein-Barr virus latent membrane protein-1 oncogene in adult ordinary, HIV-associated and paediatric Hodgkin's dis�ease. Leuk Lymphoma 2001; 40: 235–42.
   PubMed Web of Science ®Google Scholar
• Leung SY, Yuen ST, Chung LP, Chan ASY, Wong MP. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int J Cancer 1997; 72: 225–30.
   Google Scholar
• Smir BN, Hauke RJ, Bierman PJ, et al. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in postransplant lymphoproliferative disorders. Lab Invest 1996; 75: 575–88.
   PubMed Web of Science ®Google Scholar
• Sandvej K, Gratama JW, Munch M, et al. Sequence analysis of the Epstein-Barr virus (EBV) latent mem�brane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 1997; 90: 323–30.
   PubMed Web of Science ®Google Scholar
• Srivastava G, Wong KY, Chiang AKS, Lam KY, Tao Q. Coinfection by multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood 2000; 95: 2443–5.
   Google Scholar